Compare Align Technology, Inc. (ALGN) vs ING Groep NV (ING) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs ING Groep NV — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while ING Groep NV trades at $32.15 (market cap $92.53B). The key difference: ING Groep NV is far larger — about 7.2× Align Technology, Inc.'s market cap, and ING Groep NV pays a 3.91% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | ING | |
|---|---|---|
Market Cap | $12.86B | $92.53B |
Sector | Health | Financials |
52-Week High | $207.19 | $32.96 |
52-Week Low | $124.88 | $22.45 |
Enterprise Value | $11.92B | — |
Dividend Yield | — | 3.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
ING trades at $32.39, down 0.34% today, with a bullish technical outlook supported by moving averages. The company maintains strong profitability with a 27.84% net income margin and has beaten earnings expectations for three consecutive quarters. Recent developments include the launch of a global subscription banking model and a $0.88 dividend payment scheduled for May 2026.
The stock presents a compelling value opportunity with a P/E of 12.99 and strong analyst support (62.5% buy ratings). However, negative operating cash flow trends and exposure to European banking sector volatility represent key risks. Upside potential exists from continued earnings outperformance and strategic initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About ING Groep NV
The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions ING build up a global footprint. The 2008 financial crisis forced ING to seek government support--a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market- leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.
Read more on ING →
